BioNexus Gene Lab

BGLC · NASDAQ

$1.19+$0.00 (+0.00%)TodayMarket closed ·
Prev close $1.19

Who owns BGLC

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 47.5% of BGLC’s shares.

  • Fidelion Diagnostics Pte Ltd13.4%
  • Tan Lee (Su-Leng)11.6%
  • ARC Group Ltd6.0%
  • Liew (Choong-Chin)5.7%
  • Next 6 largest institutions10.9%
  • All other shareholders52.5%
Top institutional holders of BGLC
HolderShares% of shares
Fidelion Diagnostics Pte Ltd392.33K13.39%
Tan Lee (Su-Leng)338.71K11.56%
ARC Group Ltd175.00K5.97%
Liew (Choong-Chin)166.67K5.69%
Lai (Soo Kow(kenny))125.00K4.27%
Chong (Set Fui)96.77K3.30%
Bin Abdul Hamid Muhammad (Azrul)32.26K1.10%
Yap (Chee Keong)32.26K1.10%
Low (Jook Yuen)17.39K0.59%
HRT Financial LP14.28K0.49%

Largest mutual fund holders

Top mutual fund holders of BGLC
HolderShares% of shares
Blackstone Alternative Multi-Strategy Fund30.00%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of BGLC in the last 6 months.

Latest BGLC insider transactions
InsiderTypeSharesValue
Tan Lee Su-LengAward338.71K—
Yap Chee KeongAward32.26K—
Bin Abdul Hamid Muhammad AzrulAward32.26K—
Chong Set FuiAward96.77K—
Low Jook YuenAward16.13K—

Short interest

Settled Sep 30, 2026

Shares short
10.11K
Days to cover
1.50
% of shares outstanding
0.35%
Average daily volume
6.72K
Change since last report
−22.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.